This information was published on 2025-04-06T00:06:43 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2496255 (IR 1841654) |
| (220) |
05 Nov 2024
|
| (511) (510) |
Class 5
pharmaceutical drugs; pharmaceuticals; pharmaceutical substances; pharmaceutical substances and preparations |
| (540) | Alvizon |
| (550) | Word |
| (730) |
Eye Co Pty Ltd
ACN/ABN 22109283892 |
| (750) |
Oxygene IP
|
Find out more about publications on the About page.